Business Development Manager
Boehringer Ingelheim
مجموع سنوات الخبرة :26 years, 11 أشهر
Across the region was leading BD projects through which the new value is created and distinguish company propositions.
Cross functionally across the region; was leading alignment, negotiation and update required for
contracting and ensuring business handover across all relevant functions in a proactive manner
Leading internal & external communication in a way for finding optimum solutions for customers’ satisfaction, resolving complexity & conflict management, ensure deliverables achievement across \{Iran, Pakistan, Yemen, UAE\}.
• Accelerate: Developing a mutually agreed strategic set of KPI with our distributors to
ensure establishment of mutual alignment on the current and future focus areas of
development; that ensure achievement of both BI (Boehringer Ingelheim) and
partners’ vision.
• Yemen business: leading team for accessing new markets and growing with Yemen business 60% within two years.
• Pakistan; setting a clear platform for alignment and to ensure compliant accessing for new market across different functions and optimum transfer costs.
Establishing efficient implementation plan through clear set of KPI and roadmap of milestones & new enlistment; being tracked on monthly
basis.
• UAE - Outsourcing; cross functionally leading team, identifying gaps, setting action plans to transform business from declining to growing trend, achieving agreed target and a clear set of KPI.
• Proactively setting framework for ensuring company profitability goals; following up payables and ensuring receivable payments across pre agreed plans for all scope of countries/ projects
Leading Team of two RSMs and one specialty care with 17 medical reps and indirectly leading BM and
KAM. Transforming country performance, building full fledge cross functional team, agent
change management and leading new mindset of performance management.
• Leading organization growth indicators across two waves of distributors change.
• Growing business with 150%
Leading OAD Market value wise
• Leadership in rare disease market; successfully lead market of lung fibrosis.
• Growing with non-governmental business to triple times in five years.
• Bringing company within top 10 with positive MS gaining trend in both private and
Governmental one.
• Leading digitalization implementation at the time of COVID
• Leading customer engagement at the time of COVID at the level of Kuwait market
• Establishing new office in Kuwait; new structure and potential field force deployment
behind strategy implementation
• Establishing KPI tracker for distributor management
• Optimize market potential and available opportunities in all business sectors lead to
achievement of major milestones \{Private, MOH and Institution\} - establishment of
commercial agreement, patients’ help agreement, quickest registration, accessing
new market PHCs, enlisting and building strong partnership with keys stakeholders in MOH
Leading a diversified business in a very challenging and changing environment with a solid tracking records in both private and governmental sectors in Saudi Arabia.
currently leading 3 regional mangers and two key account mangers.
Unprecedented achievements in government sector in Oral Antidiabetic and Thrombolytic area
Optimizing Access for government sectors through a full fledged cross functional team
Potentially contributing in crafting and implementing of different strategic plans for different therapeutic areas for leading market share growth.
Creating a developmental environment that inspiring employee motivation and progress.
Strategic investment for catching new opportunities, opening new business and growing with current business
Setting key performance indicators essential for optimizing people and business capabilities
General MBA; the electives were on marketing communication and strategic human resources management. Dissertation was on development through appraisal system